Cambridge, MA
Nabla is an autoreverse platform that enables the rapid discovery of previously unattainable protein variants with supernatural qualities. Nabla Bio makes new medicines and improve nutrition by engineering novel proteins.
nabla.bioThese are collections Nabla Bio is a part of. Click on the collection name to view similar companies.
Series A
$26,000,000
Seed
$11,000,000
Pre Seed
$125,000
Grant
$256,000
0 out of 5 stars
Based on 0 reviews
Worked here? Share your experience. Help others decide if this company is right for them. Write a review on Nabla Bio.